Sera from 214 healthy children and adolescents (108 females [50.4%]) aged 6 months to 20 years (mean 8.7 years) and from 116 patients with rheumatic diseases were assayed for antinuclear antibody (ANA) by indirect immunofluorescence (1117) by using HEp-2 cells as substrate. Twenty-seven healthy children (12.6%) presented a positive ANA test; there was no difference between genders, and we observed a trend for higher frequency of ANA greater than or equal to 1/80 among children between 5 years and 10 years. Eight of the 27 healthy children with positive ANA test were reevaluated 36 months later, and none of them had developed any rheumatic disease, though the sera remained positive in 2 of them. ANA was present in 42/116 patients (36.2%). in...
Purpose The antinuclear antibody (ANA) test, despite all the downsides, is still considered and used...
Background: Autoimmunity is the deviation of the immune system from its natural course and evoking a...
AbstractObjectiveTo establish the abnormal title and the appropriate screening dilution for ANA (ant...
The frequency of antinuclear antibodies (ANA) and rheumatoid factor (RF) was investigated in 118 app...
Aim: To determine the positivity and prevalence of ANA in various autoimmune diseases in children. ...
Aim: To determine the positivity and prevalence of ANA in various autoimmune diseases in children. ...
Introduction: The term anti-nuclear antibody (ANA) is used to define a large group of autoantibodies...
Background Anti-nuclear antibody (ANA) testing is most commonly ordered by general pediatricians to ...
Copyright © 2014 Maria Segni et al. This is an open access article distributed under the Creative Co...
Objective. To identify features of antinuclear antibody (ANA)-HEp-2 test results that discriminate A...
Background. Antinuclear antibodies (ANA) are a hallmark of many autoimmune diseases and can be detec...
Very few data have been reported on the frequency of autoantibodies (AAs) in normal children. In the...
OBJECTIVES: To investigate the prevalence and patterns of anti-nuclear antibodies (ANA) in different...
This is an Open Access Journal / article distributed under the terms of the Creative Commons Attribu...
Some patients with rheumatoid arthritis (RA) as well as those with other collagen diseases are posit...
Purpose The antinuclear antibody (ANA) test, despite all the downsides, is still considered and used...
Background: Autoimmunity is the deviation of the immune system from its natural course and evoking a...
AbstractObjectiveTo establish the abnormal title and the appropriate screening dilution for ANA (ant...
The frequency of antinuclear antibodies (ANA) and rheumatoid factor (RF) was investigated in 118 app...
Aim: To determine the positivity and prevalence of ANA in various autoimmune diseases in children. ...
Aim: To determine the positivity and prevalence of ANA in various autoimmune diseases in children. ...
Introduction: The term anti-nuclear antibody (ANA) is used to define a large group of autoantibodies...
Background Anti-nuclear antibody (ANA) testing is most commonly ordered by general pediatricians to ...
Copyright © 2014 Maria Segni et al. This is an open access article distributed under the Creative Co...
Objective. To identify features of antinuclear antibody (ANA)-HEp-2 test results that discriminate A...
Background. Antinuclear antibodies (ANA) are a hallmark of many autoimmune diseases and can be detec...
Very few data have been reported on the frequency of autoantibodies (AAs) in normal children. In the...
OBJECTIVES: To investigate the prevalence and patterns of anti-nuclear antibodies (ANA) in different...
This is an Open Access Journal / article distributed under the terms of the Creative Commons Attribu...
Some patients with rheumatoid arthritis (RA) as well as those with other collagen diseases are posit...
Purpose The antinuclear antibody (ANA) test, despite all the downsides, is still considered and used...
Background: Autoimmunity is the deviation of the immune system from its natural course and evoking a...
AbstractObjectiveTo establish the abnormal title and the appropriate screening dilution for ANA (ant...